We have also shown that CTCs thus enriched from blood of patients with prostate cancer are positive for expression of PSMA, AMACR, EpCAM, and PanCK as determined by fluorescence immunocytochemistry (ICC).26 The gene discussed is AMACR; the disease is prostate cancer.